Target intelligence / Profile preview

Ecto-NOX disulfide-thiol exchanger 2 (ENOX2)

Target
ENOX2
Molecular classification
Enzyme, Oxidoreductase, Cell surface protein
01

Overview

Ecto-NOX disulfide-thiol exchanger 2 (ENOX2), commonly referred to as tumor-associated NADH oxidase (tNOX), is a cancer-specific cell surface glycoprotein that plays a pivotal role in regulating cell growth, proliferation, and survival. It exhibits two alternating enzymatic activities: the oxidation of NADH (or hydroquinones) and protein disulfide-thiol interchange, which generate intrinsic oscillations that act as an ultradian cellular clock linked to cell enlargement. ENOX2 is produced via cancer-specific alternative splicing and is highly expressed on the outer leaflet of the plasma membrane of various cancer cells, while being virtually absent or inactive on normal, non-transformed cells. This tumor-specific expression makes it an attractive therapeutic target and a valuable biomarker for early cancer detection through liquid biopsies.

Inhibition of ENOX2 by small molecules, such as phenoxodiol (idronoxil), ME-143, capsaicin, and epigallocatechin gallate (EGCG), blocks its enzymatic activities, leading to an accumulation of cytosolic NADH and a disruption of the intracellular NAD+/NADH ratio. This redox imbalance suppresses the activity of the NAD+-dependent deacetylase sirtuin 1 (SIRT1), thereby enhancing the acetylation of key proteins like p53 and c-Myc, which triggers cell cycle arrest and apoptosis. Additionally, ENOX2 inhibition alters sphingolipid metabolism by reducing prosurvival sphingosine-1-phosphate and elevating proapoptotic ceramide levels, further driving programmed cell death. Because of its localization on the external cell surface, drugs targeting ENOX2 do not need to enter the cell to exert their anticancer effects, offering a unique therapeutic advantage with minimized systemic toxicity.

Other names
Tumor-associated NADH oxidasetNOXCOVA1Cytosolic ovarian carcinoma antigen 1APK1 antigenTumor-associated hydroquinone oxidase
02

Mechanism of action

Inhibition of NADH oxidase and protein disulfide-thiol interchange activities, leading to accumulation of cytosolic NADH, disruption of the NAD+/NADH ratio, inhibition of SIRT1 deacetylase activity, and induction of apoptosis via sphingolipid pathway modulation (elevating ceramide and reducing sphingosine-1-phosphate).

03

Biological functions

Cell proliferationCell growthApoptosisRedox regulationCell cycleCell migrationInvasion
04

Disease associations

CancerMalignant melanomaOvarian cancerGastric cancerOral cancerLung cancer
05

Safety considerations

Potential for paradoxical upregulation at low doses (e.g., with capsaicin)Inhibition of immune cell viability or function (immunosuppression)Off-target effects on normal vascular biology or benign cells (e.g., keratinocytes, fibroblasts, melanocytes) where low-level expression may occurDevelopment of resistance when combined with other targeted therapies
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

ENOX2 expression levelSerum ENOX2 transcript variantsUrine ENOX2 levelsSIRT1 activityp53 acetylationPhospho-AKT levels

Beyond the preview

Go deeper on Ecto-NOX disulfide-thiol exchanger 2 (ENOX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ecto-NOX disulfide-thiol exchanger 2 (ENOX2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call